Antonella Agodi1,2,3, Martina Barchitta4,5, Rosalba Cipresso4, Loredana Giaquinta6, Maria Antonietta Romeo6, Carmelo Denaro6. 1. Department of Biomedical Sciences, University of Catania, Via S. Sofia 87, 95123, Catania, Italy. agodia@unict.it. 2. Gruppo Italiano Studio Igiene Ospedaliera, Catania, Italy. agodia@unict.it. 3. Laboratorio di progettazione sperimentazione e analisi di politiche pubbliche e servizi alle persone, University of Catania, Catania, Italy. agodia@unict.it. 4. Department of Biomedical Sciences, University of Catania, Via S. Sofia 87, 95123, Catania, Italy. 5. Gruppo Italiano Studio Igiene Ospedaliera, Catania, Italy. 6. Intensive Care Unit, Azienda Ospedaliera Cannizzaro, Catania, Italy.
Abstract
OBJECTIVE: We evaluated whether Pseudomonas aeruginosa associated nosocomial infections in our ICU originate mainly from patients' endogenous flora or from exogenous cross-transmission. DESIGN AND SETTING: A 6-month prospective surveillance survey was performed according to standardized protocols at the interdisciplinary ICU of the Azienda Ospedaliera Cannizzaro. PATIENTS: The study analyzed 121 patients and focused on three different states: carriage upon admission, colonization of sterile sites, and infections during ICU stay. RESULTS: We identified 138 P. aeruginosa isolates from 45 patients. The cumulative incidence of P. aeruginosa sustained colonization in the ICU was 29.9/100 patients, and the incidence density was 16.2/1,000 patient-days. The cumulative incidence of P. aeruginosa-sustained infections in the ICU was 36.7/100 patients, and the incidence density was 19.9/1,000 patient-days. The most frequent infection type was ventilator-associated pneumonia. PFGE analysis of P. aeruginosa isolates led to the identification of a major clone represented by 60.8% of isolates involving 45.9% of patients. The impact of cross-transmission, i.e., the preventable proportion of P. aeruginosa acquisition, was estimated to be at least 59.5% of all colonization or infection episodes. Acquisition of multidrug-resistant P. aeruginosa was significantly associated with cross-transmission. CONCLUSIONS: Our results suggest that the ICU personnel and environment served as reservoirs for cross-transmission and emphasize the importance of exogenous acquisition of multidrug-resistant P. aeruginosa, of reduction in antibiotic pressure, and prompt enforcement of infection control measures.
OBJECTIVE: We evaluated whether Pseudomonas aeruginosa associated nosocomial infections in our ICU originate mainly from patients' endogenous flora or from exogenous cross-transmission. DESIGN AND SETTING: A 6-month prospective surveillance survey was performed according to standardized protocols at the interdisciplinary ICU of the Azienda Ospedaliera Cannizzaro. PATIENTS: The study analyzed 121 patients and focused on three different states: carriage upon admission, colonization of sterile sites, and infections during ICU stay. RESULTS: We identified 138 P. aeruginosa isolates from 45 patients. The cumulative incidence of P. aeruginosa sustained colonization in the ICU was 29.9/100 patients, and the incidence density was 16.2/1,000 patient-days. The cumulative incidence of P. aeruginosa-sustained infections in the ICU was 36.7/100 patients, and the incidence density was 19.9/1,000 patient-days. The most frequent infection type was ventilator-associated pneumonia. PFGE analysis of P. aeruginosa isolates led to the identification of a major clone represented by 60.8% of isolates involving 45.9% of patients. The impact of cross-transmission, i.e., the preventable proportion of P. aeruginosa acquisition, was estimated to be at least 59.5% of all colonization or infection episodes. Acquisition of multidrug-resistant P. aeruginosa was significantly associated with cross-transmission. CONCLUSIONS: Our results suggest that the ICU personnel and environment served as reservoirs for cross-transmission and emphasize the importance of exogenous acquisition of multidrug-resistant P. aeruginosa, of reduction in antibiotic pressure, and prompt enforcement of infection control measures.
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: X Bertrand; M Thouverez; D Talon; A Boillot; G Capellier; C Floriot; J P Hélias Journal: Intensive Care Med Date: 2001-08 Impact factor: 17.440
Authors: J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer Journal: JAMA Date: 1995 Aug 23-30 Impact factor: 56.272
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-31 Impact factor: 17.440
Authors: Ron Balczon; K Adam Morrow; Chun Zhou; Bradley Edmonds; Mikhail Alexeyev; Jean-Francois Pittet; Brant M Wagener; Stephen A Moser; Silas Leavesley; Xiangming Zha; Dara W Frank; Troy Stevens Journal: FASEB J Date: 2017-03-17 Impact factor: 5.191
Authors: Akinobu Kamei; Andrew Y Koh; Mihaela Gadjeva; Gregory P Priebe; Stephen Lory; Gerald B Pier Journal: J Infect Dis Date: 2010-01-01 Impact factor: 5.226
Authors: Constantine J Karvellas; Fred Pink; Mark McPhail; Timothy Cross; Georg Auzinger; William Bernal; Elizabeth Sizer; Demetrios J Kutsogiannis; Ian Eltringham; Julia A Wendon Journal: Intensive Care Med Date: 2009-04-03 Impact factor: 17.440